IMMY Competitors and Similar CompaniesClear all

IMMY's competitors and similar companies include Ceterix Orthopaedics, RTI Surgical, Seegene and OrthoPediatrics.
IMMY
IMMY
IMMY is a biotech company that manufactures, markets, and distributes its own lines of diagnostic tests and reagents.
Ceterix Orthopaedics
Ceterix Orthopaedics
Ceterix Orthopaedics develops novel surgical tools for arthroscopic procedures.
RTI Surgical
RTI Surgical
RTI Surgical is a global surgical implant company providing surgeons with safe biologic, metal and synthetic implants.
Seegene
Seegene
Seegene ((주)씨젠) is a company that manufactures molecular diagnostics products.
OrthoPediatrics
OrthoPediatrics
OrthoPediatrics designs, develops, manufactures, and distributes orthopedic implants and instruments for pediatric orthopedic surgeons.
Founding Date
Founding Date
1979
Founding Date
2010
Founding Date
1998
Founding Date
2000
Founding Date
2006
Type
Type
Private
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Norman, US HQ
Locations
Fremont, US HQ
Locations
Alachua, US HQ
Metz, FR
Neunkirchen Am Brand, DE
Houten, NL
Singapore, SG
Greenville, US
Marquette, US
see more
Locations
Seoul, KR HQ
Contagem, BR
Toronto, CA
Düsseldorf, DE
Genova, IT
Ciudad De México, MX
Dubai, AE
see more
Locations
Warsaw, US HQ
Employees
Employees
943% increase
Employees
2054% increase
Employees
8915% decrease
Employees
88478% increase
Employees
9418% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
234.2 m
Valuation ($)
N/A
Valuation ($)
842.6 m
Twitter followers
Twitter followers
3.6 k
Twitter followers
243
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$280.9m (FY, 2018)
Revenue (est.)
₩367.4b (FY, 2023)
Revenue (est.)
$148.7m (FY, 2023)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$140.7m (FY, 2018)
Cost of goods
₩120.9b (FY, 2023)
Cost of goods
$37.5m (FY, 2023)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$140.1m (FY, 2018)
Gross profit
₩249.6b (FY, 2023)
Gross profit
$111.3m (FY, 2023)
Net income
Net income
N/A
Net income
N/A
Net income
($1.3m) (FY, 2018)
Net income
₩733.2m (FY, 2023)
Net income
($21m) (FY, 2023)

Operating

Countries
Countries
N/A
Countries
N/A
Countries
45 (FY, 2016)
Countries
48 (Q2, 2020)
Countries
36 (Nov, 2017)
Distributors
Distributors
N/A
Distributors
N/A
Distributors
N/A
Distributors
100 (Q3, 2022)
Distributors
31 (Nov, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 53m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 39m
For sources of this data, please see the company profile

View Company Profiles

Ceterix Orthopaedics
HQ
Fremont, US
Employees
205↑ 4% increase

Ceterix Orthopaedics develops novel surgical tools for arthroscopic procedures.

View company
RTI Surgical
HQ
Alachua, US
Employees
891↓ 5% decrease

RTI Surgical is a global surgical implant company providing surgeons with safe biologic, metal and synthetic implants.

View company
Seegene
HQ
Seoul, KR
Employees
884

Seegene ((주)씨젠) is a company that manufactures molecular diagnostics products.

View company
OrthoPediatrics
HQ
Warsaw, US
Employees
94↑ 18% increase

OrthoPediatrics designs, develops, manufactures, and distributes orthopedic implants and instruments for pediatric orthopedic surgeons.

View company